174 related articles for article (PubMed ID: 23321335)
1. Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis.
Frattini F; Crestani S; Vescovi PP; Franchini M
Hematology; 2013 May; 18(3):181-2. PubMed ID: 23321335
[TBL] [Abstract][Full Text] [Related]
2. Asacol®-induced neutropenia resolution without the use of granulocyte colony-stimulating factor.
Fowler BT; Gupta T; Bilal M
South Med J; 2010 Nov; 103(11):1167-9. PubMed ID: 20859250
[TBL] [Abstract][Full Text] [Related]
3. Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.
Fleming K; Ashcroft A; Alexakis C; Tzias D; Groves C; Poullis A
World J Gastroenterol; 2015 Mar; 21(11):3376-9. PubMed ID: 25805947
[TBL] [Abstract][Full Text] [Related]
4. [THREE CASES OF DRUG-INDUCED PNEUMONIA CAUSED BY MESALAZINE].
Akiyama N; Yokomura K; Nozue T; Abe T; Matsui T; Suda T
Arerugi; 2015 Dec; 64(10):1334-40. PubMed ID: 26727138
[TBL] [Abstract][Full Text] [Related]
5. [A case of mesalazine-induced lung injury improved by only discontinuation of mesalazine].
Shimizu T; Hayashi M; Shimizu N; Kinebuchi S; Toyama J
Nihon Kokyuki Gakkai Zasshi; 2009 Jun; 47(6):543-7. PubMed ID: 19601534
[TBL] [Abstract][Full Text] [Related]
6. Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.
Ferrusquía J; Pérez-Martínez I; Gómez de la Torre R; Fernández-Almira ML; de Francisco R; Rodrigo L; Riestra S
World J Gastroenterol; 2015 Apr; 21(13):4069-77. PubMed ID: 25852295
[TBL] [Abstract][Full Text] [Related]
7. Correction of mesalazine-induced neutropenia with high-dose G-CSF.
Bhidayasiri R; Katz JA; Sokos DR
Am J Gastroenterol; 2000 Nov; 95(11):3321-2. PubMed ID: 11095375
[No Abstract] [Full Text] [Related]
8. Ulcerative colitis patients with an inflammatory response upon mesalazine cannot be desensitized: a randomized study.
Buurman DJ; De Monchy JG; Schellekens RC; van der Waaij LA; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2015 Apr; 50(4):399-405. PubMed ID: 25633468
[TBL] [Abstract][Full Text] [Related]
9. [Interstitial pneumonia related to mesalamine].
Lamsiah T; Moudden K; Baaj M; Hadri L
Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
[TBL] [Abstract][Full Text] [Related]
10. Acute interstitial nephritis due to mesalazine.
Tadic M; Grgurevic I; Scukanec-Spoljar M; Bozic B; Marusic S; Horvatic I; Galesic K
Nephrology (Carlton); 2005 Apr; 10(2):103-5. PubMed ID: 15877665
[TBL] [Abstract][Full Text] [Related]
11. Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor.
Otsubo H; Kaito K; Sekita T; Shimada T; Kobayashi M; Hosoya T
Int J Hematol; 1998 Dec; 68(4):445-8. PubMed ID: 9885444
[TBL] [Abstract][Full Text] [Related]
12. Mesalazine allergy in a boy with ulcerative colitis: clinical usefulness of mucosal biopsy criteria.
Wada S; Kumagai H; Yokoyama K; Ito T; Miyauchi A; Sakamoto S; Imagawa T; Tulyeu J; Tanaka M; Yamagata T
Clin J Gastroenterol; 2016 Oct; 9(5):302-5. PubMed ID: 27503129
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of drug-induced intrathoracic lesions caused by mesalazine in patients with ulcerative colitis].
Machida H; Shinohara T; Hatakeyama N; Inayama M; Hosokawa E; Ogushi F
Nihon Kokyuki Gakkai Zasshi; 2011 Jul; 49(7):538-42. PubMed ID: 21842693
[TBL] [Abstract][Full Text] [Related]
14. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.
Lichtenstein GR; Kamm MA; Sandborn WJ; Lyne A; Joseph RE
Aliment Pharmacol Ther; 2008 Jun; 27(11):1094-102. PubMed ID: 18363894
[TBL] [Abstract][Full Text] [Related]
15. [Eosinophilic pneumonia caused by mesalazine. Report of one case].
Pérez C; Errázuriz I; Brockmann P; González S; Cofré C
Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary pathology in patients with ulcerative colitis treated with mesalazine--a challenging and complex diagnostic problem. Case series and literature review.
Kacprzak A; Siemion-Szcześniak I; Szturmowicz M; Bestry I; Langfort R; Kuś J
Pneumonol Alergol Pol; 2014; 82(4):368-76. PubMed ID: 24964241
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
Miner PB; Wedel MK; Xia S; Baker BF
Aliment Pharmacol Ther; 2006 May; 23(10):1403-13. PubMed ID: 16669955
[TBL] [Abstract][Full Text] [Related]
18. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
[TBL] [Abstract][Full Text] [Related]
19. Mesalazine-induced eosinophilic variant of Wegener's granulomatosis in an ulcerative colitis patient.
Fayaz M; Sultan A; Nawaz M; Sultan N
J Ayub Med Coll Abbottabad; 2009; 21(4):171-3. PubMed ID: 21067054
[TBL] [Abstract][Full Text] [Related]
20. [Myopericarditis in a patient with ulcerative colitis treated with mesalazine].
Martín M; Santamarta E; de la Iglesia JM; Saiz A
Med Clin (Barc); 2010 Jan; 134(1):43-4. PubMed ID: 19423137
[No Abstract] [Full Text] [Related]
[Next] [New Search]